GILEAD SCIENCES INC (GIS.DE) Stock Fundamental Analysis

FRA:GIS • US3755581036

131.24 EUR
+2.44 (+1.89%)
Last: Feb 13, 2026, 05:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall GIS gets a fundamental rating of 6 out of 10. We evaluated GIS against 81 industry peers in the Biotechnology industry. While GIS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on GIS. This makes GIS very considerable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year GIS was profitable.
  • GIS had a positive operating cash flow in the past year.
  • In the past 5 years GIS has always been profitable.
  • In the past 5 years GIS always reported a positive cash flow from operatings.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.86%, GIS belongs to the top of the industry, outperforming 87.65% of the companies in the same industry.
  • GIS has a Return On Equity of 37.80%. This is amongst the best in the industry. GIS outperforms 96.30% of its industry peers.
  • GIS's Return On Invested Capital of 18.54% is amongst the best of the industry. GIS outperforms 96.30% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for GIS is above the industry average of 12.03%.
  • The last Return On Invested Capital (18.54%) for GIS is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • The Profit Margin of GIS (27.88%) is better than 85.19% of its industry peers.
  • In the last couple of years the Profit Margin of GIS has declined.
  • With an excellent Operating Margin value of 38.96%, GIS belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GIS has grown nicely.
  • Looking at the Gross Margin, with a value of 78.72%, GIS is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GIS has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GIS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • GIS has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, GIS has less shares outstanding
  • GIS has a worse debt/assets ratio than last year.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • GIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.55
WACC11.93%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • GIS has a Current Ratio of 1.53. This is a normal value and indicates that GIS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of GIS (1.53) is worse than 60.49% of its industry peers.
  • GIS has a Quick Ratio of 1.17. This is a normal value and indicates that GIS is financially healthy and should not expect problems in meeting its short term obligations.
  • GIS has a Quick ratio of 1.17. This is in the lower half of the industry: GIS underperforms 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • GIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.88%, which is quite impressive.
  • GIS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.01% yearly.
  • GIS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.78%.
  • GIS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

  • Based on estimates for the next years, GIS will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.03% on average per year.
  • GIS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 19.02, the valuation of GIS can be described as rather expensive.
  • GIS's Price/Earnings ratio is rather cheap when compared to the industry. GIS is cheaper than 87.65% of the companies in the same industry.
  • GIS is valuated rather cheaply when we compare the Price/Earnings ratio to 27.67, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 17.47, GIS is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GIS indicates a rather cheap valuation: GIS is cheaper than 88.89% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.69. GIS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.02
Fwd PE 17.47
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GIS is valued cheaper than 83.95% of the companies in the same industry.
  • 90.12% of the companies in the same industry are more expensive than GIS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.31
EV/EBITDA 12.79
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GIS has an outstanding profitability rating, which may justify a higher PE ratio.
  • GIS's earnings are expected to grow with 27.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.24
PEG (5Y)N/A
EPS Next 2Y39.1%
EPS Next 3Y27.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.12%, GIS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.64, GIS pays a better dividend. On top of this GIS pays more dividend than 93.83% of the companies listed in the same industry.
  • GIS's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr Years6
Div Non Decr Years6
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

  • 12.00% of the earnings are spent on dividend by GIS. This is a low number and sustainable payout ratio.
  • GIS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

FRA:GIS (2/13/2026, 5:11:54 PM)

131.24

+2.44 (+1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap162.83B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target120.14 (-8.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend2.67
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)2.9%
PT rev (3m)7.33%
EPS NQ rev (1m)-2.7%
EPS NQ rev (3m)-12.52%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)1.07%
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)1.33%
Valuation
Industry RankSector Rank
PE 19.02
Fwd PE 17.47
P/S 6.65
P/FCF 20.31
P/OCF 20
P/B 9.01
P/tB N/A
EV/EBITDA 12.79
EPS(TTM)6.9
EY5.26%
EPS(NY)7.51
Fwd EY5.72%
FCF(TTM)6.46
FCFY4.92%
OCF(TTM)6.56
OCFY5%
SpS19.74
BVpS14.56
TBVpS-3.28
PEG (NY)0.24
PEG (5Y)N/A
Graham Number47.55
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC11.93%
ROIC/WACC1.55
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.27%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / GIS.DE FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 6 / 10 to GIS.DE.


What is the valuation status of GILEAD SCIENCES INC (GIS.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Undervalued.


How profitable is GILEAD SCIENCES INC (GIS.DE) stock?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 8 / 10.


What is the financial health of GILEAD SCIENCES INC (GIS.DE) stock?

The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 5 / 10.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 79.63% in the next year.